AD
Andrew David Chatfield
About Andrew David Chatfield
Data last updated:
Andrew David Chatfield is a Director at Pfizer Healthcare India Private Limited (since 2018) and Director at Zydus Hospira Oncology Private Limited (since 2016). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹2,412 Cr; the largest is Pfizer Healthcare India Private Limited at ₹1,981 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Pfizer Healthcare India Private Limited U24232TN2009PTC073563 | Director | 20 Dec 2018 | 2009 | ₹1,981 Cr (FY 2025) | Active |
 Zydus Hospira Oncology Private Limited U24230GJ2005PTC046246 | Director | 10 May 2016 | 2005 | ₹431 Cr (FY 2025) | Active |
Board colleagues of Andrew David Chatfield
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Andrew David Chatfield
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Andrew David Chatfield
Andrew David Chatfield currently holds 2 directorships: Pfizer Healthcare India Private Limited (Director, since 20 Dec 2018, revenue ₹1,981 Cr (FY 2025)); Zydus Hospira Oncology Private Limited (Director, since 10 May 2016, revenue ₹431 Cr (FY 2025)).
Andrew David Chatfield was first appointed on 10 May 2016 as Director at Zydus Hospira Oncology Private Limited. The most recent appointment on record is 20 Dec 2018 at Pfizer Healthcare India Private Limited.
The 2 current companies of Andrew David Chatfield that report revenue have a combined latest revenue of ₹2,412 Cr: Pfizer Healthcare India Private Limited ₹1,981 Cr (FY 2025); Zydus Hospira Oncology Private Limited ₹431 Cr (FY 2025).
The current boards of Andrew David Chatfield's companies include Andrew Gordon Mc Killop (Pfizer Healthcare India Private Limited), Fiona Kathleen Maccarthy (Pfizer Healthcare India Private Limited), Jayaraman Aparajith (Pfizer Healthcare India Private Limited), Jayaraman Aparajith (Pfizer Healthcare India Private Limited), Kannan Natarajan (Pfizer Healthcare India Private Limited), Muralidhar B Sharma (Pfizer Healthcare India Private Limited), among others.